[1] Kanerva LO, Johansson E, Niemi KM, et al. Epidermodysplasia verruciformis.Clinical and light-and electron-microscopic observations during etretinate therapy[J]. Arch Derrautol Res,1985,278(2):153-160.
[2] 陈红.维A 酸类药物的研究进展及其在皮肤科治疗中的应用[J].海峡药学,2006,18(6):94-96.
[3] 彭振辉, 牛新武.维A酸类药物与皮肤病[J].中国皮肤性病学杂志,2004,18(6):374-377.
[4] 张石革, 宋菲.维A 酸受体药物的研究进展及皮肤科临床应用评价[J].中国医院用药评价与分析,2002,2(1):12-14.
[5] 曹玲,郑枫,刘文英. LC-APCI-MSPMS 法研究维氨酯在大鼠体内的排泄[J].中国临床药理学与治疗学,2008,13( 4) : 406- 411.
[6] 吴秋菊,马鹏程,陈志强.维A 酸类药物系统用药的常见不良反应及其对策[J].国外医学皮肤性病学分册,2003,29(6):336-339.
[7] 赵辨.临床皮肤病学[M].3版.南京:江苏科学技术出版社,2001:316-317.
[8] 杨国亮,王侠生.现代皮肤病学[M].上海:上海医科大学出版社,1996:306-307.
[9] 吴建兵,林麟. 维A 酸类药物与免疫调节[J].国外医学皮肤性病学分册,2003,29(5):267-269.
[10] Anadolu R, Oskay T, Erdem C, et al. Treatment of epidermodysplasia verruciformis with a combination of acitretin and interferon alfa-2a[J]. J Am Acad Dermatol, 2001, 45(2):296-299.
[11] 林孝华,李秉煦.疣状表皮发育不良[J].中华皮肤科杂志,2005,38(9):593-595.
[12] Cooper KD, Androphy EJ, Lowy D, et al. Antigen presentation and T-cell activation in epidermodysplasia verruciformis[J]. J Invest Dennatol,1990,94(6):769-776.
[13] Majewski S, Malejezyk J, Jablonska S, et al. Natural cell-mediated cytotoxieity against various target cells in patients with epidermodysplasia verruciformis[J].J Am Acad Dermatu1,1990,22(3):423-427.
[14] Jablonska S,Obalek S,Wolska H.Follow-up of patients with epidermodysplasia verruciformis treated with etretinate[J].Dermatologica,1986,173(4):196-199.
[15] Iraji F,Faghihi G.Epidermodysplasia verrueiformis:association with isolated IgM deficiency and response to treatment with acitretin[J].Clin Exp Dermatol,2000,25(1):41-43.
[16] Ansarin H, Tajziehchi L, Shaianfar N. A case of epidermodysplasia verruciformis with squamous cell carcinomas on non-sun-exposed areas of skin [J].Arch Iranian Med,2007,10 (2): 261-263.
[17] Gubinelli E, Posteraro P, Cocuroecia B, et al. Epidermodysplasia verrueiformis with multiple mucosal carcinomas treated with pegylated interferon alfa and acitretin [J]. J Dermatolog Treat, 2003, 14(3):184-188.
[18] 韩永智,孙建方.阿维A 治疗疣状表皮发育不良1例[J].临床皮肤科杂志, 2006, 35(9):613-614.
[19] 钟连生, 魏志平, 张兴红,等. 阿维A 治疗疣状表皮发育不良1 例[J].临床皮肤科杂志, 2007,36(10):664-665.
[20] 胡兹嘉, 张宝民, 方方. 异维A酸联合手术治疗疣状表皮发育不良1例[J].中华皮肤科杂志, 1998, 31(3):196-197.
[21] 刘之力, 史月君, 刘新国.异维A酸联合他扎罗汀凝胶治疗疣状表皮发育不良1例[J].中华皮肤科杂志, 2003, 36(4):233.
[22] 高影,单立贞.三蕊胶囊联合他扎罗汀凝胶治疗疣状表皮发育不良10 例分析[J].中国药物与临床,2008,8(3):232-233. |
